Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.54−0.02 (-1.28%)
Close on Nov 18, 2026Market cap $4.66MP/E –Yield –
Intelligent Bio Solutions operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Intelligent Bio Solutions's operating income for the twelve months ending Jun 30, 2026 was -$12.61M. For fiscal 2026 it was -$12.61M. The highest annual figure on record is -$2.86M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$12.61M | – |
| FY2025 | Jun 30, 2025 | -$10.68M | – |
| FY2024 | Jun 30, 2024 | -$10.28M | – |
| FY2023 | Jun 30, 2023 | -$12.60M | – |
| FY2022 | Jun 30, 2022 | -$8.34M | – |
| FY2021 | Jun 30, 2021 | -$5.57M | – |
| FY2020 | Jun 30, 2020 | -$2.86M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$3.97M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.95M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$2.64M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$3.00M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$3.11M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$2.56M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.26M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$2.73M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$2.81M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$2.95M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.99M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$2.53M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$2.70M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$6.54M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$2.13M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$1.22M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$2.09M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$1.34M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$3.47M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$1.44M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$852.65K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$3.14M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$917.33K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$663.00K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$508.89K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$28.82K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$1.70M | – |
See a number that looks wrong?